The discovery and development of buspirone: a new approach to the treatment of anxiety.
Pharmaceutical Research and Development Division, Bristol-Myers Squibb Co., Wallingford, Connecticut 06492.
J S
JS
New
D000818:Animals; D000928:Antidepressive Agents; D002065:Buspirone / Q000031:analogs & derivatives / Q000138:chemical synthesis / Q000494:pharmacology*; D055598:Chemical Phenomena; D002621:Chemistry; D006801:Humans; D011743:Pyrimidines / Q000494:pharmacology; D051381:Rats; D011985:Receptors, Serotonin / Q000187:drug effects; D013329:Structure-Activity Relationship
D000928:Antidepressive Agents; D011743:Pyrimidines; D011985:Receptors, Serotonin; C039979:gepirone; D002065:Buspirone